ONCOTHERAPY SCIENCE INC.
OncoTherapy Science, Inc. engages in research and development of anti-body drugs; and the genome analysis of cancer, liquid biopsy, and development of new immunotherapy in Japan. Its development pipeline includes OTS167, a small molecular compound that targets the maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, … Read more
Market Cap & Net Worth: ONCOTHERAPY SCIENCE INC. (30O)
ONCOTHERAPY SCIENCE INC. (F:30O) has a market capitalization of $35.63 Million (€34.71 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #23217 globally and #2527 in its home market, demonstrating a 12.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ONCOTHERAPY SCIENCE INC.'s stock price €0.10 by its total outstanding shares 343643599 (343.64 Million).
ONCOTHERAPY SCIENCE INC. Market Cap History: 2015 to 2026
ONCOTHERAPY SCIENCE INC.'s market capitalization history from 2015 to 2026. Data shows change from $803.90 Million to $35.63 Million (-25.88% CAGR).
ONCOTHERAPY SCIENCE INC. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ONCOTHERAPY SCIENCE INC.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 30O by Market Capitalization
Companies near ONCOTHERAPY SCIENCE INC. in the global market cap rankings as of March 19, 2026.
Key companies related to ONCOTHERAPY SCIENCE INC. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ONCOTHERAPY SCIENCE INC. Historical Marketcap From 2015 to 2026
Between 2015 and today, ONCOTHERAPY SCIENCE INC.'s market cap moved from $803.90 Million to $ 35.63 Million, with a yearly change of -25.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €35.63 Million | +20.24% |
| 2025 | €29.63 Million | -17.65% |
| 2024 | €35.98 Million | -21.54% |
| 2023 | €45.86 Million | -63.07% |
| 2022 | €124.16 Million | -34.21% |
| 2021 | €188.72 Million | -39.55% |
| 2020 | €312.18 Million | +30.15% |
| 2019 | €239.86 Million | -24.53% |
| 2018 | €317.82 Million | -45.95% |
| 2017 | €588.02 Million | -22.54% |
| 2016 | €759.10 Million | -5.57% |
| 2015 | €803.90 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of ONCOTHERAPY SCIENCE INC. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.63 Million USD |
| MoneyControl | $35.63 Million USD |
| MarketWatch | $35.63 Million USD |
| marketcap.company | $35.63 Million USD |
| Reuters | $35.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.